Furthermore, the recent studies have shown the development of CP resistance in cervical cancer due to the dysregulation of genetic factors including PDHB-AS and Wnt (50), VPS13C (51), HMGB1 (52) and BRSK1 (53), among others. This evidence concerns the gene HMGB1 and cervical cancer.